[New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].

In 1966 the Swedish Council on Technology Assessment in Health Care (SBU) published a scientific review of estrogen treatment following menopause. A new report by SBU has now reviewed, classified and graded the scientific literature on hormone replacement therapy 1995-2001. In some cases the scientific evidence has become stronger (risk for breast cancer after long-term treatment) while in other cases the uncertainty identified in the earlier report remains (effect on cardiovascular disease and stroke).